The purpose of this study was to determine whether liraglutide is more effective than metformin in the treatment of obese women with newly diagnosed polycystic ovary syndrome (PCOS). We anticipated greater changes in body weight in patients treated with liraglutide than in those treated with metformin.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
32
University Medical Center Ljubljana
Ljubljana, Slovenia
The main outcome was change in body weight.
Time frame: Patient's body weight was mesured at the base point and every four weeks during 12 weeks of clinical trial.
The secondary outcome was change in body mass index (BMI)
Patient's BMI was defined as the patient's body mass in kilograms divided by the square of their height in meters.
Time frame: Patient's body weight were measured at the base point and every four weeks during the 12 weeks of clinical trial. Patient's height was measured at the basepoint.
The secondary outcome was change in waist circumference.
Patient's waist circumference was measured in centimeters.
Time frame: Patient's waist circumference was measured at the basepoint and every four weeks during 12 weeks of clinical trial.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.